AU3867797A - Recombinant mpo fragment and method for assaying mpo autoantibody reaction site by using the same - Google Patents

Recombinant mpo fragment and method for assaying mpo autoantibody reaction site by using the same

Info

Publication number
AU3867797A
AU3867797A AU38677/97A AU3867797A AU3867797A AU 3867797 A AU3867797 A AU 3867797A AU 38677/97 A AU38677/97 A AU 38677/97A AU 3867797 A AU3867797 A AU 3867797A AU 3867797 A AU3867797 A AU 3867797A
Authority
AU
Australia
Prior art keywords
mpo
assaying
fragment
same
reaction site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38677/97A
Inventor
Kazuo Suzuki
Masaru Tanokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Publication of AU3867797A publication Critical patent/AU3867797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU38677/97A 1996-08-21 1997-08-21 Recombinant mpo fragment and method for assaying mpo autoantibody reaction site by using the same Abandoned AU3867797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-219855 1996-08-21
JP21985596 1996-08-21
PCT/JP1997/002910 WO1998007848A1 (en) 1996-08-21 1997-08-21 Recombinant mpo fragment and method for assaying mpo autoantibody reaction site by using the same

Publications (1)

Publication Number Publication Date
AU3867797A true AU3867797A (en) 1998-03-06

Family

ID=16742120

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38677/97A Abandoned AU3867797A (en) 1996-08-21 1997-08-21 Recombinant mpo fragment and method for assaying mpo autoantibody reaction site by using the same

Country Status (2)

Country Link
AU (1) AU3867797A (en)
WO (1) WO1998007848A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE465172T1 (en) * 2004-03-05 2010-05-15 Univ Illinois PEPTIDE CARRIER FOR DRUG ADMINISTRATION
US20090162876A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Myeloperoxidase assays
US20150017665A1 (en) * 2012-01-03 2015-01-15 The University Of North Carolina At Chapel Hill Peptides and Methods for Detecting MPO-ANCA
JP6607436B2 (en) * 2014-07-31 2019-11-20 株式会社Ａ−Ｃｌｉｐ研究所 Novel MPO-ANCA test method to identify pathological conditions of intractable vasculitis
JP2017146271A (en) * 2016-02-19 2017-08-24 国立大学法人 千葉大学 Method of testing for vasculitis

Also Published As

Publication number Publication date
WO1998007848A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU4992997A (en) Humanized anti-cd11a antibodies
AU3447097A (en) Method for producing recombinant adenovirus
AU6232898A (en) Method and system for branch prediction
AU9400098A (en) Improved sample inspection system
AU5297698A (en) System and method for determining an operating point
AU4467497A (en) Chaperone fragments
AU4404097A (en) Direction determining apparatus
AU2815597A (en) High elongation reinforcement for concrete
AU5291098A (en) Pipe lining method
AU1672297A (en) Cladding material
AU6798198A (en) Method for verifying the location of an array of detectors
AU1595699A (en) Method and apparatus for integrating organic fibers with mineral fibers
AU8177898A (en) Method for monitoring an induced fracture with vsp
AUPM645394A0 (en) Brick cladding method
AU3867797A (en) Recombinant mpo fragment and method for assaying mpo autoantibody reaction site by using the same
AU1284899A (en) Sample retrieval system
AU3326597A (en) Immunoassay method
AU5064798A (en) Apparatus for manufacturing roofing or cladding panels
AU9091798A (en) Method and apparatus for the manufacture of roof cladding elements
AU4524596A (en) Recombinant antigen for diagnosing rheumatoid arthritis
AU4468496A (en) A method for predicting protein structure
AUPP403098A0 (en) Method and system for selection candidates for employment
AU8407798A (en) Inspection system with specimen preview
AU7558998A (en) Method for reinforcing
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin